Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA ...

With a simple click, doctors can potentially save lives and reduce heart attack and stroke risks for thousands of patients by ...

Millions of Medicaid beneficiaries have limited access to Type 2 diabetes medications that reduce the risk of cardiovascular disease, according to a study published April 22 in Annals of Internal ...

According to a pharmacist, people taking some prescription medications may be unaware that they are risking vitamin and ...

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, significantly reduced hemoglobin A1c (HbA1c) in adults with type 2 diabetes (T2D) and inadequate glycemic control with diet ...

A UF study finds that two common diabetes drugs may help protect against Alzheimer’s disease in older adults with Type 2 ...

Research shows that regular users of marijuana are at risk for serious conditions, including strokes, heart attacks, cardiac ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.